Acessibilidade
A+
A-
Institucional

Governance

Em Temas Materiais:

Data privacy and information security

The Company’s ability to protect the personal and confidential data of its customers, professionals, and partners.

Leia mais

Em Global Reporting Initiative:

/ Universal Standards - General Disclosures

GRI 2-9

We believe our commitment to the best corporate governance practices helps us to ensure the business sustainability and to serve the interests of all RD Saúde’s stakeholders: customers, investors, suppliers, employees, community, government, trade unions and associations, among others. We maintain an ethical and strong relationship with these stakeholders, ensuring that everyone has access to […]
Leia mais

GRI 2-10

Aiming at the diversity of experience and knowledge of the board members, the selection criteria are established in the Policy for Appointment and Election of Board Members and take into account the qualifications and experience in areas such as finance, health, technology, people management, ESG and specialization in pharmaceutical retail, in addition to reputation and […]
Leia mais

GRI 2-11

Currently, the Executive Board is led by the Chief Executive Officer (CEO), who does not hold a position on the Board of Directors.
Leia mais

GRI 2-12

See here detailed information about our advisory committees of the Board of Directors. (link levando para o indicador 2-9)
Leia mais

GRI 2-13

The Sustainability Committee is responsible for monitoring, updating and validating the guidelines, strategies and commitments related to sustainable development taking into account ESG risks and opportunities, including the climate agenda, in addition to overseeing the work of the Sustainability Officer. This Committee meets approximately once a month over the year, with the exception of January […]
Leia mais

GRI 2-14

The content of the Annual and Sustainability report was initially defined based on the materiality process, which is approved by Senior Management. Then, information was collected from different areas, deepened through interviews with advisors, officers and other executives responsible for the Company’s planning and strategy. The Report was also approved by RD Saúde’s Senior Management.
Leia mais

GRI 2-15

Employees and administrators must declare potential situations of conflict of interest through a statement to the Ethics and Compliance area. If an administrator is faced with a potential conflict of interest in a decision, he/she must communicate this conflict and abstain from participating in the discussion about and vote on such matter. These actions must […]
Leia mais

GRI 2-16

Our risk management is based on the best national and international practices, such as ISO 31000 and COSO ERM, and those of the Brazilian Institute of Corporate Governance (IBGC) and the Institute of Internal Auditors of Brazil (IIA). Additionally, the risk management process undergoes periodic auditing, conducted by internal auditing in conjunction with specialized external […]
Leia mais

GRI 2-17

The Bylaws outline the responsibilities of the Vice President of People, Culture, and Sustainability in relation to sustainable development. In the same vein, the Board of Directors’ Internal Regulations refer to the perpetuity of the corporate purpose as a sustainable business, the creation of sustainable business value, and the responsibilities of the Sustainability Committee in […]
Leia mais

GRI 2-18

The Board of Directors conducts an annual and formal evaluation of its performance, following best corporate governance practices and seeking continuous improvement of this governance body. The evaluation is carried out by an external and independent consultancy, and consists of two stages: individual and of the body as a whole. Its methodology includes interviews, online […]
Leia mais

GRI 2-19

Administrators’ compensation is determined in accordance with the provisions of the Executive Board Compensation Policy, market practices, and our corporate governance and management system. It is evaluated on a regular basis, with the support of specialized consultants, taking into account factors such as inflation, pay increments, and industry trends. The Board of Directors receives only […]
Leia mais

GRI 2-20

All employees at RD Saúde are eligible to variable compensation through the Profit Sharing Program (PPR), which considers the achievement of corporate goals. The objective is to reward individuals for their own performance and that of the Company, as well as to challenge our people to be co-responsible for business results and share successes and […]
Leia mais

GRI 2-21

The ratio of the total annual compensation for the company’s highest-paid individual to the medium annual total compensation for all employees was 327 times. The ratio of the percentage increase in annual total compensation for the company’s highest-paid individual to the medium percentage increase in annual total compensation for all employees was 18%. The following […]
Leia mais

GRI 2-23

In order to ensure an ethical culture and righteous conduct in all RD Saúde’s activities, we rely on management policies and guidelines approved by the Board of Directors. The documents are part of the Integrity Program and aim, in addition to controlling risks, to guide the mitigation, remediation and management of consequences of any ethical, […]
Leia mais

GRI 2-24

Upon joining the Company, all employees must complete a course on the People Code at RD Saúde University platform, in addition to signing a statement of responsibility and commitment to the expected ethical conduct. Since 2022, human rights risks have been integrated into our corporate risk matrix, which is managed under the Risk Management Program. […]
Leia mais

GRI 2-26

We are pleased to offer the Canal Conversa Ética, our Whistleblowing Channel, to the entire society. This channel is available 24/7, and receives complaints about any conduct that violates national laws, our policies, procedures, and values. The channel allows for anonymous reporting and provides you with the ability to track the progress of your report. […]
Leia mais

GRI 2-27

There were no cases of non-compliance with laws and regulations during the reporting period
Leia mais

GRI 2-30

Collective bargaining agreements are entered into with unions and cover 100% of professionals, who are represented by the Retail Pharmaceutical Products Trade Union in each state and municipality, totaling 299 unions.
Leia mais

/ Topic Standards - Economic - Economic Performance

GRI 201-3

RD Saúde does not offer a retirement plan to its employees. The Company makes the monthly payment of the Social Security contribution on behalf of its employees to the National Institute of Social Security (INSS), which is responsible for the payment of retirement and other benefits to Brazilian workers (Act No. 8,213, dated July 24, […]
Leia mais

GRI 201-4

At RD, we carry out social investment through tax incentives. Therefore, in 2023, we created the Tax Incentive Use Policy (link: https://ri.rd.com.br/list.aspx?idCanal=ebcBJMy5wkUA4JCROsKQLg==&linguagem=pt), which aims to defend, regulate and implement our interests in the use of federal tax incentives, defining the roles and responsibilities of everyone involved. These investments are also based on the Theory of […]
Leia mais

/ Topic Standards - Economic - Market Presence

GRI 202-1

The lowest salary paid by RD Saúde in 2023 for male and female employees was BRL 1,412.00 compared to the Brazilian minimum wage, of BRL 1,320.00. This represents a ratio of 1.07 for both genders. Salaries are determined based on either the minimum wage or the collective bargaining agreement salary floor, to which the professionals […]
Leia mais

/ Topic Standards - Economic - Anti-corruption

GRI 205-1

We evaluate 100% of operations. In the “Unethical Conduct” risk category, we monitor the following risk factors: 1. acts of corruption carried out by employees or contractors on behalf of RD Saúde; 2. lack of ethical conduct procedures for controlled companies; 3. lack of guidelines for relationships with government officials; 4. conflicts of interest for […]
Leia mais

GRI 205-2

In 2023, 17,089 people completed the course on the People Code at RD Saúde University platform, aimed at our employees. In addition, 24 members of governance bodies (100%) and 57,216 employees (100%) were informed about anti-corruption policies and procedures. There was no training on the topic for members of governance bodies. Find out details about […]
Leia mais

/ Tópicos materiais - Environment - Anti-corruption

GRI 205-3

In 2023, there were no confirmed incidents of corruption in RD Saúde.
Leia mais

/ Tópicos standards - Social - Diversity and Equal Opportunity

GRI 405-1

Indivíduos dentro dos órgãos de governança em 2023 órgão de governança por gênero por faixa etária por identidade autodeclarada de raça homem mulher abaixo de 30 anos entre 30 e 50 anos acima de 50 anos amarelos negros brancos pardos Conselho de Administração 72,70% 27,30% 0,00% 36,40% 63,60% 0,00% 0,00% 100,00% 0,00% Diretoria Estatutária 87,50% […]
Leia mais

GRI 405-2

Proporção entre o salário-base e a remuneração recebidos pelas mulheres e aqueles recebidos pelos homens 2021 2022 2023 salário-base remuneração salário-base remuneração salário-base remuneração Liderança executiva 92,86% 86,26% 92,28% 83,63% 87,55% 81,53% Liderança média 96,85% 95,83% 94,25% 93,96% 92,81% 92,92% Liderança operacional 99,97% 99,86% 100,95% 100,90% 101,79% 101,77% Especialista 72,64% 71,74% 76,95% 76,20% 73,33% 73,69% […]
Leia mais

/ Tópicos standards - Social - Non-discrimination

GRI 406-1

In 2023, 209 cases were registered regarding the topic “discrimination”, of which 182 have already been analyzed and completed, including: 77 valid and partially valid; 91 invalid; 12 inconclusive; 2 with insufficient data; and 27 reports under investigation. The measures taken in relation to the 182 completed calls include: written warning (17), verbal warning (5), […]
Leia mais

/ Tópicos standards - Social - Security Practices

GRI 410-1

98%, considering 15 own employees and other contractors.
Leia mais

/ Tópicos standards - Social - Supplier Social Assessment

GRI 414-1

In 2023, 100% of the 1,692 new suppliers were selected based on social criteria.
Leia mais

GRI 414-2

In 2023, 9,531 suppliers were evaluated against social criteria. Among them, 2,120 were identified as causing actual and potential negative impacts. Non-conformities were identified in 176 partners, mainly related to the requirements for providing pre-employment physical examination certificates, the wearing of PPE, paying overtime worked, and labor requirements provided by law. In 2023, no relationships […]
Leia mais

/ Tópicos standards - Social - Public Policy

GRI 415-1

We do not make political contributions.
Leia mais

/ Tópicos standards - Social - Customer Privacy

GRI 418-1

We adopt the best market practices to ensure information security through frameworks such as NIST, CIS Controls, and ISO/IEC 27001:2022, among others. To strengthen our incident detection and response capabilities, we have: • 24/7 monitoring of security events from a Security Operation Center (SOC); • Monitoring of potential data leaks using DLP (Data Loss Prevention) […]
Leia mais

Em SASB:

/ Data security and privacy

HC-DR-230a.1

RD Saúde maintains a comprehensive compliance program that includes permanent technical and organizational measures designed to ensure data security, robust internal governance, and ongoing training for teams and professionals.Our Company’s compliance program has been built on several pillars since its inception: (a) structuring an internal Data Privacy and Information Security Governance team; (b) appointing an […]
Leia mais

HC-DR-230a.2

1) We have not recorded any data leaks, breaches, or other indications of unauthorized access to personal and/or sensitive data;2) 0%;3) We have not recorded any data leaks, breaches, or other indications of unauthorized access to personal and/or sensitive data.
Leia mais

HC-DR-230a.3

There were no monetary losses related to this matter.
Leia mais

/ Patient health outcomes

HC-DR-260b.3

In 2024, we made payments totaling BRL 258,606.71 related to 24 legal cases involving prescription dispensing errors.
Leia mais

Em TCFD:

/ Governance

a) Describe the Board's oversight of climate-related risks and opportunities.

The Board of Directors is supported by the Sustainability Committee, which meets at least ten times a year to assess the progress of actions and performance of our sustainability strategy—including our climate change mitigation and adaptation plan. The outcomes of these meetings are reported to the Board members. In addition to fixed agendas, Committee members […]
Leia mais

b) Describe management's role in assessing and managing climate-related risks and opportunities.

In recent years, RD Saúde has advanced in the climate agenda and integrated it into routine scenario analyses and evaluations of factors that may impact the Company, either positively or negatively. The Risk Committee, which advises the Board, identifies, measures, and monitors climate-related risks and opportunities in coordination with business areas, and defines processes to […]
Leia mais

/ Strategy

a) Describe climate-related risks and opportunities the organization has identified over the short, medium, and long term.

With ESG practices integrated into our corporate strategy, we use the Corporate Risk Matrix to anticipate risks, identify opportunities, and ensure business continuity. Risks and opportunities are assessed based on quantitative and qualitative criteria and classified according to their likelihood of occurrence and business impact. This approach enables us to design effective responses to financial, […]
Leia mais

b) Describe the impacts of climate-related risks and opportunities on the organization’s businesses, strategy, and financial planning.

Risks and opportunities are reflected in our 2030 Commitments, which guide investment and financial decisions over the short, medium, and long term. Several areas of the Company, such as Engineering, Risk Management, and Operations, work together to implement mitigation actions, including projects for the development of sustainable low-emission products and services, fleet decarbonization, and more […]
Leia mais

c) Describe the resilience of the organization’s strategy, taking into consideration different climate-related scenarios, including a 2°C or lower scenario.

RD Saúde has developed a consistent mitigation and adaptation strategy that strengthens business resilience in the face of climate change: we maintain a high percentage of electricity consumption from renewable sources and have implemented energy efficiency solutions; we invest in training our drivers and optimizing processes to increase vehicle efficiency; we expanded the volume of […]
Leia mais

/ Risk management

a) Describe the organization's processes for identifying and assessing climate-related risks.

To ensure a structured, science-based approach, in 2024 we conducted a detailed climate risk assessment covering all our operational assets, including the RD Saúde Campus, 14 Distribution Centers, and 3,230 pharmacies. Physical and transition risks were mapped in collaboration with business areas, analyzed by impact and likelihood of occurrence, and classified according to the Company’s […]
Leia mais

b) Describe the organization's processes for managing climate-related risks.

The review and monitoring of RD Saúde’s risks (including climate risks) are primarily conducted by the Risk Management Committee, an advisory body to the Executive Board, which holds regular meetings specifically to monitor risks according to their nature. This phase includes monitoring key risk indicators (KRIs), tracking the progress of previously defined action plans, and […]
Leia mais

c) Describe how processes for identifying, assessing and managing climate-related risks are integrated into the organization's overall risk management.

Since 2022, we have incorporated climate risks into the Company’s overall risk matrix. The Risk Management team ensures ongoing alignment with the Sustainability Department and with business areas directly involved in addressing and monitoring climate risks.
Leia mais

/ Metrics and targets

a) Disclose the metrics used by the organization to assess climate-related risks and opportunities in line with its strategy and risk managment process.

With ESG practices integrated into our corporate strategy, we use the Corporate Risk Matrix to anticipate risks, identify opportunities, and ensure business continuity. Risks and opportunities are assessed using quantitative and qualitative criteria and classified according to likelihood of occurrence and business impact. This approach enables effective responses to financial, reputational, operational, regulatory compliance, health […]
Leia mais

c) Describe the targets used by the organization to manage climate-related risks and opportunities and performance against targets.

In 2023, we revisited our 2030 sustainability commitments and updated our climate-related goals. We committed to: In addition, in 2024 we also achieved the following targets: supply 100% of operations with renewable energy and develop a tactical decarbonization plan for the Transportation area—both tied to the variable compensation of all corporate professionals, with greater weight […]
Leia mais

Em MSCI:

/ Enviromental & Social

Product carbon footprint

Risk Management Extent of product carbon footprint assessments We have carbon emissions assesments on the use of sold product and end-of-life treatment of sold products. Assessment of energy consumption and/or carbon emissions of suppliers In 2022, we began using CDP Supply Chain as a means to engage suppliers and encourage the disclosure of their emissions, […]
Leia mais
© 2025 RaiaDrogasil – Todos os direitos reservados. Produzido por Plank